Skip to main content

Table 1 Patients characteristics

From: Pembrolizumab activity in patients with Fanconi anemia repair pathway competent and deficient tumors

Enrolled patients, No. (evaluable)

41 (39)

Median Age, Y (Range)

62 (36–83)

Sex

34 F, 7 M

Race/ethnicity

14 W, 3 AA, 1 A, 23 Ha

Median No. of prior regimens (range)

2 (1–7)

Primary diagnosis

 Ovarian

11

 Endometrial

9 (2 carcino-sarcomas)

 Pancreatic

2

 Colorectal

4 (1 neuro-endocrine)

 Cervical

2

 Fallopian

2

 Vaginal

2

 Head and neck

2 (1 adenoid cystic),

 Breast, esophagus, small-cell lung, small bowel, thymic, vulvar, Mullerian

1 each

  1. aW White, AA African American, A Asian, H Hispanic/Latino